SCHEMBL2106482

SCHEMBL2106482

Cc1cc([C@@H](C)NC(=O)c2ccc3nc(C(C)(C)C)ccc3c2)c(Cl)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
MAPK1 P28482 2/20 0.38
LMNA P02545 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TDP1 Q9NUW8 1/20 0.35
KLKB1 P03952 1/20 0.35
MAP4K1 Q92918 1/20 0.35
PDE2A O00408 1/20 0.34
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
CDK2 P24941 1/20 0.34
AKT1 P31749 1/20 0.34
PPARG P37231 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2106651 1.00 MEN1 (0.41) MEN1KMT2AMAPK1LMNATAS1R3
SCHEMBL2106773 0.91 MEN1 (0.39) MEN1KMT2AMAPK1TAS1R3TAS1R1
SCHEMBL1754350 0.87 TAS1R3 (0.44) MEN1KMT2ATAS1R3TAS1R1CYP1A2
SCHEMBL1753973 0.87 TAS1R3 (0.46) MEN1KMT2AMAPK1LMNATAS1R3
SCHEMBL3292156 0.87 TAS1R3 (0.46) MEN1KMT2AMAPK1LMNATAS1R3
SCHEMBL1753950 0.87 TAS1R3 (0.46) MEN1KMT2AMAPK1LMNATAS1R3
SCHEMBL1754353 0.83 KMT2A (0.44) MEN1KMT2ALMNATAS1R3TAS1R1
SCHEMBL2361366 0.83 KMT2A (0.44) MEN1KMT2ALMNATAS1R3TAS1R1
SCHEMBL2108087 0.80 CYP1A2 (0.38) MEN1KMT2ALMNATDP1CYP1A2
SCHEMBL2328729 0.79 CYP1A2 (0.39) MEN1KMT2ALMNATDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158650-B2 Substituted phenylmethyl bicyclocarboxyamide compounds PFIZER INC. (US) 2012-04-17 US claimed
EP-2222631-B1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER (US) 2011-08-17 EP claimed
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER INC. 2010-04-08 US claimed
EP-2222631-B1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS PFIZER (US) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087480-A1 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS TRPV1, P2RY1, TRPV2 MEN1 4681/4885KMT2A 2843/4885MAPK1 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.